ZONISADE
Total Payments
$39,205
Transactions
363
Doctors
245
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $24,490 | 355 | 241 |
| 2023 | $14,715 | 8 | 5 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $32,108 | 9 | 81.9% |
| Food and Beverage | $7,097 | 354 | 18.1% |
Top Doctors Receiving Payments for ZONISADE — Page 10
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Student in an Organized Health Care Education/Training Program | Saint Louis, MO | $16.65 | 1 |
| , PA | Physician Assistant | Omaha, NE | $16.65 | 1 |
| , MBBS | Pediatrics | Lexington, KY | $16.65 | 1 |
| , MD PHD | Neurology with Special Qualifications in Child Neurology | Chicago, IL | $16.65 | 1 |
| , DNP, APRN-NP, CPNP | Pediatrics | Omaha, NE | $16.65 | 1 |
| , MD | Epilepsy | Shenandoah, TX | $16.38 | 1 |
| , CPNP | Pediatrics | Shenandoah, TX | $16.38 | 1 |
| , M.D | Specialist | Lake Success, NY | $16.00 | 1 |
| Carolina Marquez | Pediatrics | Miami, FL | $15.34 | 1 |
| , MD | Neurology with Special Qualifications in Child Neurology | Indianapolis, IN | $14.60 | 1 |
| , M.D | Neurology | Livingston, NJ | $14.31 | 1 |
| , M.D | Neurology | Fort Wayne, IN | $14.24 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Louisville, KY | $14.23 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Louisville, KY | $14.23 | 1 |
| , MD | Neurology | Kokomo, IN | $14.16 | 1 |
| , MD | Psychiatry | Kokomo, IN | $14.16 | 1 |
| , RPA-C | Medical | Williamsville, NY | $13.08 | 1 |
| , CPNP-PC | Pediatrics | Amherst, NY | $13.08 | 1 |
| , RPA-C | Physician Assistant | Orchard Park, NY | $13.08 | 1 |
| , RPA-C | Physician Assistant | Amherst, NY | $13.08 | 1 |
Ad
Manufacturing Companies
- Azurity Pharmaceuticals, Inc. $39,205
Product Information
- Type Drug
- Total Payments $39,205
- Total Doctors 245
- Transactions 363
About ZONISADE
ZONISADE is a drug associated with $39,205 in payments to 245 healthcare providers, recorded across 363 transactions in the CMS Open Payments database. The primary manufacturer is Azurity Pharmaceuticals, Inc..
Payment data is available from 2023 to 2024. In 2024, $24,490 was paid across 355 transactions to 241 doctors.
The most common payment nature for ZONISADE is "Consulting Fee" ($32,108, 81.9% of total).